Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis

Journal of Dermatological Science

Volumn 53, Issue 1, 2009, Pages 48-54

  Yamaguchi, Junko ^a   Aihara, Michiko ^a   Kobayashi, Yusuke ^b   Kambara, Takeshi ^a   Ikezawa, Zenro ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHISEIDO RESEARCH CENTER   (Japan)

Author keywords

Atopic dermatitis; Horny layer; Nerve growth factor; Olopatadine; Tape stripping method

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN E; LACTATE DEHYDROGENASE; NERVE GROWTH FACTOR; OLOPATADINE;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LICHENOID ERUPTION; MALE; PAPULE; PRIORITY JOURNAL; PRURITUS; PSORIASIS; QUANTITATIVE ANALYSIS; RASH; STRATUM CORNEUM; XEROSIS;

ADULT; CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; DIBENZOXEPINS; EPIDERMIS; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; IMMUNOGLOBULIN E; L-LACTATE DEHYDROGENASE; MALE; NERVE GROWTH FACTOR; PRURITUS; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 57549087772     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.08.011     Document Type: Article

References (46)

1. Akdis C.A., Akdis M., Bieber T., et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy. Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 118 1 (2006) 152-169
2. Huang C.H., Kuo I.C., Xu H., et al. Mite allergen induces allergic dermatitis with concomitant neurogenic inflammation in mouse. J Invest Dermatol 121 2 (2003) 289-293
3. Peters E.M., Raap U., Welker P., et al. Neurotrophins act as neuroendocrine regulators of skin homeostasis in health and disease. Horm Metab Res 39 2 (2007) 110-124
4. Levi-Montalcini R. The nerve growth factor 35 years later. Science 234 (1987) 1154-1162
5. Levi-Montalcini R., Dal Toso R., della Valle F., et al. Update of the NGF saga. J Neurol Sci 130 (1995) 119-127
6. Yoshioka T., Hikita I., Asakawa M., et al. Spontaneous scratching behaviour in DS-Nh mice as a possible model for pruritus in atopic dermatitis. Immunology 118 3 (2006) 293-301
7. Marconi A., Terracina M., Fila C., et al. Expression and function of neurotrophins and their receptors in cultured human keratinocytes. J Invest Dermatol 121 6 (2003) 1515-1521
8. Toyoda M., Nakamura M., Makino T., et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147 (2002) 71-79
9. Pincelli C., Sevignani C., Manfredini R., et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 103 1 (1994) 13-18
10. Botchkarev V.A., Yaar M., Peters E.M., et al. Neurotrophins in skin biology and pathology. J Invest Dermatol 126 8 (2006) 1719-1727
11. Pincelli C., and Marconi A. Autocrine nerve growth factor in human keratinocytes. J Dermatol Sci 22 2 (2000) 71-79
12. Dou Y.C., Hagstromer L., Emtestam L., and Johansson O. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res 298 (2006) 31-37
13. Toyoda M. Useful therapeutic markers of atopic dermatitis: neurogenic factors. Skin Res (2005) 87-93
14. Schulte-Herbrüggen O., Fölster-Holst R., von Elstermann M., et al. Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis. Int Arch Allergy Immunol 144 3 (2007) 211-216
15. Hanifin J., and Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venerol 92 (1980) 44-47
16. Tamura T., Matsubara M., Takada C., et al. Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice. Br J Dermatol 151 6 (2004) 1133-1142
17. Glieler U., Niemeier V., Brosig B., and Kupfer J. Psychosomatic aspects of pruritus. Dermatol Psychosom 3 (2002) 6-13
18. Kawashima M., Tango T., Noguchi T., et al. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. Br J Dermatol 148 6 (2003) 1212-1221
19. Anand P., Foley P., Navsaria H.A., et al. Nerve growth factor levels in cultured human skin cells: effect of gestation and viral transformation. Neurosci Lett 184 3 (1995) 157-160
20. Lambiase A., Bracci-Laudiero L., Bonini S., et al. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol 100 (1997) 408-414
21. Leung M.S., and Wong C.C. Expressions of putative neurotransmitters and neuronal growth related genes in Merkel cell-neurite complexes of the rats. Life Sci 66 16 (2000) 1481-1490
22. Raychaudhuri S.P., Jiang W.Y., and Farber E.M. Psoriatic keratinocytes express high levels of nerve growth factor. Acta Derm Venereol 78 2 (1998) 84-86
23. Raychaudhuri S.P., and Raychaudguri S.K. Role of NGF and enurogenic inflammation in the pathogenesis of psoriasis. Prog Brain Res 146 (2004) 433-437
24. Kinkelin I., Motzing S., Koltenzenburg M., and Brocker E.B. Increase in NGF content and nerve fiber sprouting in human allergic contact eczema. Cell Tissue Res 302 (2000) 31-37
25. Tam S.Y., Tsai M., Yamaguchi M., et al. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood 90 (1997) 1807-1820
26. Torcia M., Bracci-Laudiero L., Lucibello M., et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85 (1996) 345-356
27. Burgi B., Otten U.H., Ochensberger B., et al. Basophil printing by neurotrophic factors. Activation through the trk receptor. J Immunol 157 (1996) 5582-5588
28. Ritter A.M., Woodbury C.J., Albers K., et al. Maturation of cutaneous sensory neurons from normal and NGF-overexpressing mice. J Neurophysiol 83 (2000) 1722-1732
29. Yamaoka J., Di Z.H., Sun W., and Kawana S. Changes in cutaneous sensory nerve fibers induced by skin-scratching in mice. J Dermatol Sci 46 1 (2007) 41-51
30. Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Dermatol 10 2 (2000) 85-90
31. Torcia M., Bracci-Laudiero L., Lucibello M., et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85 3 (1996) 345-356
32. Brodie C., Oshiba A., Renz H., et al. Nerve growth-factor and anti-CD40 provide opposite signals for the production of IgE in interleukin-4-treated lymphocytes. Eur J Immunol 26 1 (1996) 171-178
33. Senba E., and Kashiba H. Sensory afferent processing in multi-responsive DRG neurons. Prog Brain Res 113 (1996) 387-410
34. Lindsay R.M., and Harmar A.J. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 337 6205 (1989) 362-364
35. Imayama S., Shibata Y., and Hori Y. Epidermal mast cells in atopic dermatitis. Lancet 346 8989 (1995) 1559
36. Groneberg D.A., Bester C., Grutzkau A., et al. Mast cells and vasculature in atopic dermatitis-potential stimulus of neoangiogenesis. Allergy 60 1 (2005) 90-97
37. Takano N., Sakurai T., and Kurachi M. Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an Atopic Dermatitis Model. J Pharmacol Sci 99 3 (2005) 277-286
38. Takano N., Sakurai T., Ohashi Y., and Kurachi M. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model. Br J Dermatol 156 2 (2007) 241-246
39. Ikemura T., Okarmura K., Sasaki Y., et al. KW-4679-induced inhibition of tachykininergic contraction in the guinea-pig bronchi by prejunctional inhibition of peripheral sensory nerves. Br J Pharmacol 117 5 (1996) 967-973
40. Kanda N., and Watanabe S. Histamine enhances the production of nerve growth factor in human keratinocytes. J Invest Dermatol 121 3 (2003) 570-577
41. Kojima M., Aihara M., Yamada M., et al. Effects of neuropeptides in the development of the atopic dermatitis of mouse models. Allergol Intern 53 (2004) 169-178
42. Izu K., and Tokura Y. The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis. J Dermatol 32 10 (2005) 776-781
43. Braun A., Appel E., Baruch R., et al. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 28 10 (1998) 3240-3251
44. Tamura T., Matsubara M., Hasegawa K., et al. Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity. Clin Exp Allergy 35 1 (2005) 97-103
45. Tamura T, Amano T, Ohmori K, Manabe H. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice. Eur J Pharmacol 2005;524(1-3):149-54.
46. Norris D.A. Mechanisms of action of topical therapies and the rationale for combination therapy. J Am Acad Dermatol 53 1 (2005) S17-S25